Article Text

Download PDFPDF
Case report
Complete resolution of arrhythmia-induced hydrops fetalis in utero
  1. Monisha Narayanan1,
  2. Sypara Dhuka2,
  3. Srilatha Alapati3 and
  4. Robert P Kauffman4
  1. 1Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas, USA
  2. 2Obstetrics and Gynecology, Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas, USA
  3. 3Pediatrics, Texas Tech University Health Sciences Center School of Medicine, Amarillo, Texas, USA
  4. 4OB-GYN, Texas Tech University Health Science Center School of Medicine, Amarillo, Texas, USA
  1. Correspondence to Dr Robert P Kauffman; robert.kauffman{at}ttuhsc.edu

Abstract

A 21-year-old G3P2011 Caucasian woman at 27 weeks’ gestation presented with fetal tachyarrhythmia between 240 and 270 beats per minute. Fetal supraventricular tachycardia, abdominal ascites, pleural effusion and pericardial effusion indicated hydrops fetalis. Management with digoxin and flecainide converted the fetus to sinus rhythm and resolved the ascites and pleural effusion within 4 days of treatment. Flecainide was discontinued at 31 weeks’ gestation due to elevated liver enzymes. Intrahepatic cholestasis was treated with ursodiol. Caesarean section was performed at 37 weeks’ gestation. Neonatal echocardiogram revealed a bicuspid aortic valve with mild regurgitation and a patent foramen ovale, and the infant showed no subsequent evidence of tachyarrhythmia or hydrops after delivery. Treatment of hydrops fetalis in the antenatal period is complex, and early diagnosis and treatment can quickly resolve supraventricular tachycardia-induced hydrops fetalis.

  • materno-fetal medicine
  • neonatal health
  • pregnancy
View Full Text

Statistics from Altmetric.com

Footnotes

  • Twitter @rkauffmd

  • Contributors MN and SD performed background research and cowrote the original manuscript. SA managed the patient during the course of pregnancy and assisted with preparation of the manuscript. RPK reviewed and edited the manuscript and formulated all images.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.